WRBY
Warby Parker Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$22.50
−6.95%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.09
- Revenue estimate
- $245.1M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.13
- EPS estimate
- $0.10
- Revenue actual
- $235.5M
- Revenue estimate
- $238.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- -1.4%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $30
- PT range
- $28 – $33
- Analysts
- 3
2 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.10 | $0.13 | Beat 27.45% | $235.5M |
| May 7, 2026 | $0.11 | $0.12 | Beat 7.14% | $242.4M |
| Feb 26, 2026 | $0.05 | $0.02 | Miss -62.32% | $212.0M |
| Nov 6, 2025 | $0.09 | $0.11 | Beat 22.22% | $221.7M |
| Aug 7, 2025 | $0.08 | $0.08 | In line | $214.5M |
| May 8, 2025 | $0.12 | $0.12 | In line | $223.8M |
| Feb 27, 2025 | $0.03 | $0.01 | Miss -66.67% | $190.6M |
| Nov 7, 2024 | $0.05 | $0.05 | In line | $192.4M |
| Aug 8, 2024 | $0.05 | $0.06 | Beat 20.00% | $188.2M |
| May 9, 2024 | $0.07 | $0.08 | Beat 14.29% | $200.0M |
| Feb 28, 2024 | -$0.00 | -$0.01 | Miss -232.23% | $161.9M |
| Feb 28, 2023 | -$0.02 | -$0.17 | Miss -663.36% | $146.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026